Description
Fibrinolysis inhibiting factor is an immunomodulatory peptide with the sequence GPRP. This peptide induces acute immune hemolysis in hepatectomy models via thymic atrophy.
Fibrinolysis inhibiting factor is an immunomodulatory peptide with the sequence GPRP. This peptide induces acute immune hemolysis in hepatectomy models via thymic atrophy.
Purity | ≥98% |
---|---|
Formula | C18H31N7O5 |
Formula Wt. | 425.49 |
IUPAC Name | (2S)-1-[(2S)-2-[[(2S)-1-(2-aminoacetyl)pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carboxylic acid |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet | F3206 Info Sheet PDF |
---|
Nakatsuji T. Acceleration of thrombosis and hemolysis by fibrinolysis inhibiting factor and suppression by Ia antigen expressed on T cells in partially hepatectomized Lewis rats. Int J Hematol. 1996 Oct;64(3-4):181-8. PMID: 8923779.
LKT Labs
LKT实验室是一家专注于小分子的合成、纯化和分离的生化供应公司,用于研究应用。它的产品系列展示了已知的生物活性,在广泛的研究领域,特别是癌症和神经科学中得到了广泛的应用。这些产品包括蛋白激酶抑制剂、离子通道调节剂和激活剂。
LKT Laboratories is a biochemical supply company focused on the synthesis, purification, and isolation of small molecules for research applications. Its range of products exhibit known biological activities that have found uses in a wide array of research fields, especially cancer and neuroscience. These products include protein kinase inhibitors, ion channel modulators, and activators.
品牌 |
货号 |
名称 |
规格 |
LKT Labs |
444912-48-5 |
(2-iodo-5-nitrophenyl)-[1-[(1-methylpiperidin-2-yl)methyl]indol-3-yl]methanone |
1mg 5mg 25mg |
LKT Labs |
294646-77-8 |
(R)-CR8 |
1mg 5mg |
LKT Labs |
2377-31-3 |
(Z)-1,-BIS(2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL)DIAZENE OXIDE |
1mg 5mg 25mg |